Assoc. Prof. Dr. Feng Zhao | nanomaterials biosafety | Best Researcher Award
Institute of High Energy Physics
Profile
🎓 Early Academic Pursuits
Feng Zhao embarked on his academic journey in the field of life sciences, laying the foundation for his research career through early involvement at prestigious institutions. From 2003 to 2005, he was engaged in research at the Biology Department of Tsinghua University, Beijing—one of China’s top universities—where he honed his knowledge and experimental skills in biological sciences, with a growing interest in the interface of nanotechnology and biology.
đź’Ľ Professional Endeavors
Since 2005, Feng Zhao has been a key researcher at the Lab for Bio-Environmental Health Sciences of Nanoscale Materials, within the Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing. His long-standing tenure reflects both dedication and impact in the field of nanomaterials and their interaction with biological systems. At IHEP, he has worked on highly interdisciplinary projects bridging nanotechnology, toxicology, immunology, and environmental health.
🔬 Contributions and Research Focus
Feng Zhao’s research primarily revolves around the biological effects and biomedical applications of nanoscale materials. He has focused on investigating cellular responses, toxicological profiles, and therapeutic potentials of various nanomaterials including carbon nanotubes, metal nanomaterials, perovskite structures, and ZIF frameworks. His work explores the safe-by-design philosophy to develop nanomaterials that are both efficient in biomedical applications and safe for human use.
🌍 Impact and Influence
Dr. Zhao’s work has been featured in leading international journals such as Advanced Materials, Nano Today, Frontiers in Immunology, Advanced Healthcare Materials, and Science Bulletin. His research has contributed to advancing our understanding of nanotoxicology, nanocarriers for drug delivery, and photodynamic therapy for cancer immunotherapy. These studies not only address fundamental science but also have direct applications in clinical translation, public health, and regulatory safety standards for nanomaterials.
📊 Academic Citations and Publications
Feng Zhao has co-authored numerous high-impact publications with prominent collaborators, including Yuliang Zhao and Zhanjun Gu. His research articles have been cited extensively, contributing to the global discourse on nanotoxicology and nanomedicine. Notably:
-
His 2025 Nano Today paper introduced a novel hypocrellin B derivative for cancer immunotherapy.
-
The 2023 Nanomaterials article demonstrated telomerase inhibitor delivery using ZIF-8.
-
The 2019 Advanced Materials paper presented a pivotal “Safe-by-Design” strategy for nanomedicine.
🛠️ Technical Skills
Feng Zhao possesses deep technical expertise in nanomaterial synthesis, nanotoxicity testing, cell ceultur, drug delivery systems, photodynamic therapy, and bioaccumulation studies. He is proficient in in vitro/in vivo models, confocal microscopy, electron microscopy, flow cytometry, and other analytical and imaging techniques critical for evaluating nanomaterial interactions in biological systems.
👨‍🏫 Teaching and Mentorship
While not explicitly detailed in the records, Feng Zhao's long tenure at research institutions suggests active participation in graduate student supervision, postdoctoral mentorship, and academic collaboration. Given his association with the Chinese Academy of Sciences and co-authorship with early-career researchers, it is likely that he plays a role in shaping the next generation of scientists in nanobiotechnology and environmental health.
đź§ Legacy and Future Contributions
Feng Zhao’s contributions represent a bridge between material science and biomedicine, with a firm grounding in environmental and human health safety. His future research is expected to expand into personalized nanomedicine, immunoengineering, and real-time bio-nanosensor development, while continuing to champion the importance of safe design and biocompatibility in nanotechnology. His legacy will likely include pioneering frameworks for risk assessment and safe innovation in emerging nano-based healthcare solutions.
Selected Publications
Authors: Jixing Cheng†, Jinxia Li†, Jiasheng Wu, Weiyan Kang, Kaijie Feng, Yue You, Chuqi Wan, Yiting Zheng, Liang Yan, Ru Liu, Feng Zhao*, Yunhui Li*
Journal: Nano Today
Year: 2025
Authors: Shunyu Zhang, Jinxia Li, Liang Yan, Yue You, Feng Zhao*, Jixing Cheng, Limin Yang, Yanqi Sun, Qingchao Chang, Ru Liu, Yunhui Li*
Journal: Nanomaterials
Year: 2023
Authors: Yang Wei†, Xuejiao Gao†, Feng Zhao†, Didar Baimanov, Yalin Cong, Yingying Jiang, Saima Hameed, Yixin Ouyang, Xingfa Gao*, Xiaoying Lin*, Liming Wang*
Journal: Frontiers in Immunology
Year: 2021
Authors: Liang Yan+, Feng Zhao+, Jing Wang, Yan Zu, Zhanjun Gu*, Yuliang Zhao*
Journal: Advanced Materials
Year: 2019
Authors: Jiani Xie, Chengyan Wang, Feng Zhao*, Zhanjun Gu*, Yuliang Zhao*
Journal: Advanced Healthcare Materials
Year: 2018